Usefulness of omalizumab in ten patients with severe occupational asthma.
Fiche publication
Date publication
juin 2013
Journal
Allergy
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BONNIAUD Philippe
Tous les auteurs :
Lavaud F, Bonniaud P, Dalphin JC, Leroyer C, Muller D, Tannous R, Mangiapan G, De Blay F
Lien Pubmed
Résumé
The management of severe occupational asthma (OA) remains problematic and new alternative treatments providing better disease control are required, ideally enabling affected individuals to remain in their job.
Mots clés
Adult, Anti-Asthmatic Agents, therapeutic use, Antibodies, Anti-Idiotypic, therapeutic use, Antibodies, Monoclonal, Humanized, therapeutic use, Asthma, Occupational, drug therapy, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Male, Middle Aged, Omalizumab, Severity of Illness Index, Treatment Outcome
Référence
Allergy. 2013 Jun;68(6):813-5